Clinical Trial

Michigan Contraceptive Access, Research, and Evaluation

Study Description

Michigan Contraceptive Access, Research, and Evaluation Study

M-CARES will use large-scale administrative data complemented by follow-up surveys and a randomized control trial (RCT) to estimate the causal impact of greater financial access to contraception on a comprehensive set of outcomes. Outcomes include contraceptive use, pregnancy, childbearing, and parenting strategies; partnership decisions and relationship quality; health and health care use; education, labor market success, and public assistance receipt; financial security; neighborhood quality; mental health and stress; and life plans. The resulting estimates will inform a more complete understanding of the costs and benefits of financial access to contraception and, therefore, the investment value of related policies and programs.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Behavioral - Gift card to be used for contraceptives that is valued at 50% of cost of name-brand IUD (August 18, 2018-March 3, 2019)

M-CARES will randomize allocation of vouchers (gift cards) for contraception valued up to 50% of inserting a name-brand IUD (e.g., Skyla, Paraguard, Mirena) for women with out of pocket costs at Planned Parenthood. This intervention occurred between August 18, 2018, and March 3, 2019.

Behavioral - Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-November 4, 2019)

M-CARES will randomize allocation of vouchers (gift cards) for contraception valued up to 100% of inserting a name-brand IUD (e.g., Skyla, Paraguard, Mirena) for women with out of pocket costs at Planned Parenthood. This intervention occurred after March 3, 2019.

Behavioral - Gift card to be used for contraceptives continues to be valued at 100% of the cost of name-brand IUDs but out-of-pocket costs increase in control group (November 5, 2019 forward)

Beginning after November 4, Planned Parenthood of Michigan (PPMI) withdrew from Title X and increased the out-of-pocket costs for contraceptives for women fee scale 2/B and above as well as fee scale 1/A patients if they are over 21. The M-CARES vouchers continues to cover 100% of inserting a name-brand IUD for all women with out-of-pocket costs at Planned Parenthood. This intervention occurred after November 4, 2019.

Additional Information

Official Study Title

Michigan Contraceptive Access, Research, and Evaluation Study

Clinical Trial ID

NCT03673007

ParticipAid ID

eZ68Re